COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,386 Articles (22,816 medRxiv, 8,570 bioRxiv)

Most recent first Previous |  Page 1535: Articles 15341-15350  | Next

Rapidly emerging SARS-CoV-2 B.1.1.7 sub-lineage in the United States of America with spike protein D178H and membrane protein V70L mutations
Shen, L., Dien Bard, J., Triche, T. J., Judkins, A. R., Biegel, J. A., Gai, X.
10.1101/2021.05.14.21257247 — Posted: 2021-05-18
Effectiveness of BNT162b2 mRNA vaccine and ChAdOx1 adenovirus vector vaccine on mortality following COVID-19
Lopez Bernal, J., Andrews, N., Gower, C., Stowe, J., Tessier, E., Simmons, R., Ramsay, M.
10.1101/2021.05.14.21257218 — Posted: 2021-05-18
Symptom profiles and accuracy of clinical definitions for COVID-19 in the community. Results of the Virus Watch community cohort.
Fragaszy, E., Shrotri, M., Geismar, C., Aryee, A., Beale, S., Braithwaite, I., Byrne, T., Fong, W. L. E., Gibbs, J., Hardelid, P., Kovar, J., Lampos, V. E., Nastouli, E., Navaratnam, A. M. D., Nguyen, V. G., Patel, P., Aldridge, R. W., Hayward, A., Virus Watch Collaborative
10.1101/2021.05.14.21257229 — Posted: 2021-05-18
Long-term symptoms after SARS-CoV-2 infection in school children: population-based cohort with 6-months follow-up. Short Report
Radtke, T., Ulyte, A., Puhan, M. A., Kriemler, S.
10.1101/2021.05.16.21257255 — Posted: 2021-05-18 Discussion: Onsite | Offsite
Patient Characteristics in Cases of Reinfection or Prolonged viral shedding in SARS-CoV-2
Yoo, R. M., Romero, R. A., Mabajen, J., Mehrotra, S., Kohane, I. S., Sheils, N. E.
10.1101/2021.05.14.21257231 — Posted: 2021-05-18
Inhibitor screening of Spike variants reveals the heterogeneity of neutralizing antibodies to COVID-19 infection and vaccination
Zhang, X., Zheng, M., Liang, T., Zhou, H., Wang, H., Zhang, J., Ren, J., Peng, H., Li, S., Bian, H., Wei, C., Yin, S., He, C., Han, Y., Li, M., Hou, X., Zhang, J., Xie, L., Lv, J., Kan, B., Wang, Y., yu, x.
10.1101/2021.05.15.21257254 — Posted: 2021-05-18
Distinct Mucoinflammatory Phenotype and the Immunomodulatory Long Noncoding Transcripts Associated with SARS-CoV-2 Airway Infection
Devadoss, D., Acharya, A., Manevski, M., Pandey, K., Borchert, G. M., Nair, M., Mirsaeidi, M. S., Byrareddy, S. N., Chand, H. S.
10.1101/2021.05.13.21257152 — Posted: 2021-05-18
The specter of Manaus: the risks of a rapid return to pre-pandemic conditions after COVID-19 vaccine rollout
Van Egeren, D., Stoddard, M., Novokhodko, A., Rogers, M., Joseph-McCarthy, D., Zetter, B., Chakravarty, A.
10.1101/2021.05.14.21257250 — Posted: 2021-05-18
Persistence of functional memory B cells recognizing SARS-CoV-2 variants despite loss of specific IgG
Winklmeier, S., Eisenhut, K., Taskin, D., Ruebsamen, H., Schneider, C., Eichhorn, P., Keppler, O. T., Klein, M., Mader, S., Kuempfel, T., Meinl, E.
10.1101/2021.05.15.21257210 — Posted: 2021-05-18
SARS-CoV-2 infection risk during delivery of childhood vaccination campaigns: a modelling study
Procter, S. R., Abbas, K. R., Flasche, S., Griffiths, U., Hagedorn, B., O'Reilly, K. M., CMMID COVID-19 Working Group, , Jit, M.
10.1101/2021.05.14.21257215 — Posted: 2021-05-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).